Leukemia
Leukemia
08/17/2017
The US Food and Drug Administration has approved a new option for adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia.
08/17/2017
Hematology
Hematology
08/02/2017
After results from a recent trial demonstrated its efficacy, the FDA expanded the indication of a cancer drug to include adult patients with chronic graft versus host disease who do not respond to other...
08/02/2017
Chemotherapy
Chemotherapy
08/01/2017
The FDA granted accelerated approval to a new treatment for adolescent and adult patients with mismatch repair deficient and microsatellite instability metastatic colorectal cancer.
08/01/2017
Melanoma
Melanoma
07/24/2017
The FDA has expanded the approval of an intravenous injection for the treatment of metastatic or unresectable melanoma to include use in pediatric patients.
07/24/2017
Colorectal cancer
Colorectal cancer
06/30/2017
The first-and-only fully human monoclonal anti-epidermal growth factor receptor antibody for the treatment of wild-type RAS metastatic colorectal cancer was recently approved by the US Food and Drug...
06/30/2017
Oncology
Oncology
12/14/2015
The FDA approved new options for non-small cell lung cancer, von Willebrand disease, and to treat overdoses of certain chemotherapies.
12/14/2015
Melanoma
Melanoma
10/28/2015
The FDA has approved new options for the treatment of melanoma lesions, soft tissue sarcomas, and the rare metabolic disease, hypophosphatasia, that clinicians should be aware of.
10/28/2015
Cancer
Cancer
10/22/2015
The FDA has approved new options for the treatment of patients with hyperkalemia, metastatic pancreatic cancer, and hereditary Factor X deficiency.
10/22/2015